Insider Trading & Ownership - Becker Daniel J.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Becker Daniel J.
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2024-07-17
Sale		2024-07-19
6:18 pm		ACELYRIN Inc.SLRNBecker Daniel J.
Director		1$6.86$72,999
(Direct)		View
2023-05-09
Purchase		2023-05-11
9:02 pm		ACELYRIN Inc.SLRNBecker Daniel J.
Director		3,000$18$54,00026,243
(Direct)		View
2021-06-01
Purchase		2021-06-01
9:50 pm		Day One Biopharmaceuticals Inc.DAWNBecker Daniel J.
Director		5,000$16$80,00068,000
(Direct)		View
2020-11-19
Purchase		2020-11-23
5:30 pm		Pandion Therapeutics Inc.PANDBecker Daniel J.
Director		197,716$15.12$2,989,4662,827,883
(Indirect)		View
2020-11-17
Purchase		2020-11-19
8:15 pm		Pandion Therapeutics Inc.PANDBecker Daniel J.
Director		29,394$15.29$449,4002,630,167
(Indirect)		View
2020-07-21
Purchase		2020-07-21
7:39 pm		Pandion Therapeutics Inc.PANDBecker Daniel J.
Director
10% Owner		723,222$18$13,017,9962,615,770
(Indirect
Direct)		View
2019-11-20
Purchase		2019-11-22
8:07 pm		Principia Biopharma Inc.PRNBBecker Daniel J.
Director		55,000$29.94$1,646,700667,600
(Indirect)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2024-06-07
Option Award		2024-06-11
7:14 pm		N/A
2034-06-06		ACELYRIN Inc.SLRNBecker Daniel J.
Director		92,158$092,158
(Direct)		View
2023-06-22
Option Award		2023-06-26
7:15 pm		N/A
2033-06-21		Day One Biopharmaceuticals Inc.DAWNBecker Daniel J.
Director		37,500$037,500
(Direct)		View
2023-05-09
Other		2023-05-11
9:02 pm		N/A
2033-05-03		ACELYRIN Inc.SLRNBecker Daniel J.
Director		46,486$026,243
(Direct)		View
2023-05-04
Option Award		2023-05-04
8:11 pm		N/A
2033-05-03		ACELYRIN Inc.SLRNBecker Daniel J.
Director		23,243$023,243
(Direct)		View
2022-06-21
Option Award		2022-06-23
6:08 pm		N/A
2032-06-20		Day One Biopharmaceuticals Inc.DAWNBecker Daniel J.
Director		28,700$028,700
(Direct)		View
2021-05-26
Option Award		2021-06-01
9:50 pm		N/A
2031-05-25		Day One Biopharmaceuticals Inc.DAWNBecker Daniel J.
Director		63,000$068,000
(Direct)		View

Ownership		2021-05-26
9:01 pm		N/A
2031-05-22		Day One Biopharmaceuticals Inc.DAWNBecker Daniel J.
Director		0$063,000
(Direct)		View
2021-04-01
Disposition		2021-04-01
7:49 pm		N/A
2030-07-16		Pandion Therapeutics Inc.PANDBecker Daniel J.
Director		13,997$00
(Direct)		View
2021-04-01
Equity Swap		2021-04-01
7:49 pm		N/A
N/A		Pandion Therapeutics Inc.PANDBecker Daniel J.
Director		2,828,883$600
(Direct)		View
2020-09-28
Disposition		2020-09-28
5:24 pm		N/A
2028-09-12		Principia Biopharma Inc.PRNBBecker Daniel J.
Director		40,955$00
(Direct)		View
2020-09-28
Equity Swap		2020-09-28
5:24 pm		N/A
N/A		Principia Biopharma Inc.PRNBBecker Daniel J.
Director		667,600$1000
(Indirect)		View
2020-07-17
Option Award		2020-07-21
7:39 pm		N/A
2030-07-16		Pandion Therapeutics Inc.PANDBecker Daniel J.
Director
10% Owner		13,997$02,615,770
(Direct)		View
2020-07-21
Conversion		2020-07-21
7:39 pm		N/A
N/A		Pandion Therapeutics Inc.PANDBecker Daniel J.
Director
10% Owner		11,458,013$02,615,770
(Indirect)		View

Ownership		2020-07-16
8:16 pm		N/A
N/A		Pandion Therapeutics Inc.PANDBecker Daniel J.
Director
10% Owner		0$01,878,551
(Indirect)		View
2020-06-04
Option Award		2020-06-08
8:03 pm		N/A
2030-06-03		Principia Biopharma Inc.PRNBBecker Daniel J.
Director		10,240$010,240
(Direct)		View